What is STXS's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.11B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for STXS?

P/E (TTM) is n/a and 52-week range is $1.09 to $3.59 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s STXS figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for STXS?

The company profile lists revenue (TTM) near $30M, net income (TTM) near $-2.22B, EPS (TTM) near $-0.23 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Stereotaxis Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in St. Louis, Missouri, US, 99.6M shares outstanding, ISIN US85916J4094 when available from company profile and filing metadata.

Stereotaxis Inc

$STXS

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$1.11

+0.00%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 131 full-time employees. The company went IPO on 2004-08-12. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Employees

131

Website

www.stereotaxis.com/

IPO

2004-08-12

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)